Foley Partner Harold Wegner and Senior Counsel Jim Ewing spoke at the American Conference Institute’s (ACI) 10th Advanced Forum on Biotech Patents in Boston, Massachusetts on September 15, 2008.
Mr. Wegner spoke on Key Biotech Cases to Watch and How They May Impact Your Practice, in his presentation he covered the following:
- Upcoming cases on the Court’s roster and discussed their impact on biotech patent practices.
Mr. Ewing spoke on Navigating the Board of Patent Appeals and Interferences in Light of the KSR decision. Mr. Ewing covered these key points:
- Examining BPAI decisions in light of KSR and the direct affect on the biotechnology industry and its attempt to appeal unfavorable decisions
- Tracking trends post-KSR: what you can expect when appealing your decisions
- The other options: Exploring alternative remedies for protecting your biotech patent outside of the BPAI and the PTO
- Developing an effective biotech patent strategy when the BPAI and the Federal Circuit are in conflict
- Predicting the impact of increase public scrutiny of the BPAI
- Potential changes to the BPAI should the caseload rise, and what they may mean for the patent appeal process
For more information on ACI, please click here.
People
Related Insights
05 December 2024
Events
Relationships and Raising: How Female & Non-Binary Founders Can Leverage Networks for Fundraising
03 December 2024
Blogs
Supply Chain Integrity: Essential Insights for Multinational Automotive Companies
The U.S. government has increasingly emphasized the importance of supply chain integrity, particularly in relation to eliminating forced labor.
02 December 2024
Labor & Employment Law Perspectives
Department of Labor Clarifies Family and Medical Leave Act Leave Includes Treatment in Clinical Trials
As our readers are aware, eligible employees may take leave under the Family and Medical Leave Act for the treatment of a serious health condition.